Literature DB >> 19687343

Arterial destiffening with atorvastatin in overweight and obese middle-aged and older adults.

Jeb S Orr1, A Laura Dengo, Jose M Rivero, Kevin P Davy.   

Abstract

We hypothesized that atorvastatin (ATOR) treatment would reduce arterial stiffness in overweight and obese middle-aged and older adults. Twenty-six (11 men and 15 women) overweight or obese (body mass index: 31.6+/-0.7 kg/m(2)) middle-aged and older adults (age: 54+/-2 years) were randomly assigned to receive either ATOR (80 mg/d) or placebo for 12 weeks. Arterial stiffness (beta-stiffness and pulse wave velocity) was measured before and after the intervention. At baseline, the ATOR (n=16) and placebo (n=10) groups did not differ with respect to age, body mass index, blood pressure, serum lipid and lipoprotein concentrations, high-sensitivity C-reactive protein, indices of arterial stiffness, or compliance (all P>0.05). After the 12-week treatment period, the ATOR group experienced a 47% reduction in low-density lipoprotein cholesterol (149+/-6 to 80+/-8 mg/dL) and a 42% reduction in high-sensitivity C-reactive protein (3.6+/-0.8 to 2.1+/-0.5 mg/L; both P<0.05). In addition, beta-stiffness (9.4+/-0.6 to 7.6+/-0.5 U) and aortic pulse wave velocity (1096+/-36 to 932+/-32 cm/s), but not brachial pulse wave velocity, decreased (both P<0.05) with ATOR. In contrast, there were no significant changes in beta-stiffness (9.1+/-0.8 to 9.1+/-0.7 U) or aortic pulse wave velocity (1238+/-89 to 1191+/-90 cm/s; both P>0.05) in the placebo group. There were no relations between the reductions in arterial stiffness indices and any of the baseline cardiometabolic risk factors (all P>0.05). However, the reductions in arterial stiffness were correlated with the reduction in low-density lipoprotein cholesterol but not high-sensitivity C-reactive protein or any other cardiometabolic variables (all P<0.05). Taken together, these findings suggest that ATOR reduces arterial stiffness in overweight and obese middle-aged and older adults, and these favorable changes occur irrespective of baseline cardiometabolic risk factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19687343     DOI: 10.1161/HYPERTENSIONAHA.109.138248

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  24 in total

Review 1.  Strategies for Achieving Healthy Vascular Aging.

Authors:  Kristen L Nowak; Matthew J Rossman; Michel Chonchol; Douglas R Seals
Journal:  Hypertension       Date:  2018-01-08       Impact factor: 10.190

2.  Aortic pulse wave velocity is associated with measures of subclinical target organ damage.

Authors:  Thais Coutinho; Stephen T Turner; Iftikhar J Kullo
Journal:  JACC Cardiovasc Imaging       Date:  2011-07

Review 3.  Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation?

Authors:  Henry Fok; J Kennedy Cruickshank
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

4.  Arterial stiffness and hypertension.

Authors:  Gary F Mitchell
Journal:  Hypertension       Date:  2014-04-21       Impact factor: 10.190

5.  Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease.

Authors:  Kristen L Nowak; Heather Farmer; Melissa A Cadnapaphornchai; Berenice Gitomer; Michel Chonchol
Journal:  Nephrol Dial Transplant       Date:  2017-02-01       Impact factor: 5.992

6.  Arterial destiffening with weight loss in overweight and obese middle-aged and older adults.

Authors:  A Laura Dengo; Elizabeth A Dennis; Jeb S Orr; Elaina L Marinik; Elizabeth Ehrlich; Brenda M Davy; Kevin P Davy
Journal:  Hypertension       Date:  2010-03-08       Impact factor: 10.190

7.  Effects of cranberry juice consumption on vascular function in patients with coronary artery disease.

Authors:  Mustali M Dohadwala; Monika Holbrook; Naomi M Hamburg; Sherene M Shenouda; William B Chung; Megan Titas; Matthew A Kluge; Na Wang; Joseph Palmisano; Paul E Milbury; Jeffrey B Blumberg; Joseph A Vita
Journal:  Am J Clin Nutr       Date:  2011-03-16       Impact factor: 7.045

8.  Aging and vascular endothelial function in humans.

Authors:  Douglas R Seals; Kristen L Jablonski; Anthony J Donato
Journal:  Clin Sci (Lond)       Date:  2011-05       Impact factor: 6.124

9.  Improvement of arterial stiffness by reducing oxidative stress damage in elderly hypertensive patients after 6 months of atorvastatin therapy.

Authors:  Junhong Wang; Jian Xu; Chuanwei Zhou; Ying Zhang; Di Xu; Yan Guo; Zhijian Yang
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-06       Impact factor: 3.738

10.  The Effect of Atorvastatin on Vascular Function and Structure in Young Adult Survivors of Childhood Cancer: A Randomized, Placebo-Controlled Pilot Clinical Trial.

Authors:  Kara L Marlatt; Julia Steinberger; Kyle D Rudser; Donald R Dengel; Karim T Sadak; Jill L Lee; Anne H Blaes; Daniel A Duprez; Joanna L Perkins; Julie A Ross; Aaron S Kelly
Journal:  J Adolesc Young Adult Oncol       Date:  2017-08-30       Impact factor: 2.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.